Patents by Inventor Steven Gilman

Steven Gilman has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20050287136
    Abstract: In accordance with the present invention, there are provided fully human monoclonal antibodies against human cytotoxic T-lymphocyte antigen 4 (CTLA-4). Nucelotide sequences encoding and amino acid sequences comprising heavy and light chain immunoglobulin molecules, particularly contiguous heavy and light chain sequences spanning the complementarity determining regions (CDRs), specifically from within FR1 and/or CDR1 through CDR3 and/or within FR4, are provided. Further provided are antibodies having similar binding properties and antibodies (or other antagonists) having similar functionality as antibodies disclosed herein.
    Type: Application
    Filed: May 12, 2005
    Publication date: December 29, 2005
    Inventors: Douglas Hanson, Mark Neveu, Eileen Mueller, Jeffrey Hanke, Steven Gilman, C. Davis, Jose Corvalan
  • Patent number: D318369
    Type: Grant
    Filed: January 23, 1989
    Date of Patent: July 23, 1991
    Inventor: Steven Gilman